Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-323a regulates ERBB4 and is involved in depression
Laura M. Fiori, Aron Kos, Rixing Lin, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 8, pp. 4191-4204
Open Access | Times Cited: 74

Showing 26-50 of 74 citing articles:

NGR4 and ERBB4 as Promising Diagnostic and Therapeutic Targets for Metabolic Disorders
Maria Vulf, Maria Bograya, Alexandra Komar, et al.
Frontiers in Bioscience-Elite (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 10
L1CAM+ extracellular vesicles derived from the serum of adolescents with major depressive disorder induce depression-like phenotypes in adolescent mice
Jing Liao, Jie Liu, Yang Zhou, et al.
Journal of Affective Disorders (2025)
Closed Access
Peripheral microRNA signatures in adolescent depression
Alice Morgunova, Nicholas O’Toole, François M. Abboud, et al.
Biological Psychiatry Global Open Science (2025), pp. 100505-100505
Open Access
Effects of the LINC00641/miR-323a-3p/EIF4G2 axis on behaviors and brain monoamine neurotransmitters in chronic unpredictable mild stress mice
Lin Zhou, Qi Dong, Yongbo Zhang
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Prefrontal ErbB4-positive interneurons for avoidance
Wanpeng Cui, Chen Shen, Wen‐Cheng Xiong, et al.
Cell Reports (2025) Vol. 44, Iss. 5, pp. 115628-115628
Open Access
Exploration of the relationship between gut microbiota and fecal microRNAs in patients with major depressive disorder
Hui‐Mei Chen, Yu-Chu Ella Chung, Hsi‐Chung Chen, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
Yue Du, Jinxue Wei, Zijian Zhang, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 19
MiR-323a regulates ErbB3/EGFR and blocks gefitinib resistance acquisition in colorectal cancer
Yuanzhou Zhang, Shunshun Liang, Bowen Xiao, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 14
Depressive disorder and antidepressants from an epigenetic point of view
Iris Šalamon Arčan, Katarina Kouter, Alja Videtič Paska
World Journal of Psychiatry (2022) Vol. 12, Iss. 9, pp. 1150-1168
Open Access | Times Cited: 13
SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants
Rixing Lin, Aron Kos, Juan Pablo López, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 8
Region-specific microRNA alterations in marmosets carrying SLC6A4 polymorphisms are associated with anxiety-like behavior
Natalia Popa, Dipankar Bachar, Angela Roberts, et al.
EBioMedicine (2022) Vol. 82, pp. 104159-104159
Open Access | Times Cited: 12
MicroRNA‐146a‐5p protects retinal ganglion cells through reducing neuroinflammation in experimental glaucoma
Han Zhou, Rui‐Kang Yang, Qian Li, et al.
Glia (2024) Vol. 72, Iss. 11, pp. 2115-2141
Closed Access | Times Cited: 2
Weapons of stress reduction: (R,S)-ketamine and its metabolites as prophylactics for the prevention of stress-induced psychiatric disorders
Briana K. Chen, Christine A. Denny
Neuropharmacology (2022) Vol. 224, pp. 109345-109345
Open Access | Times Cited: 11
The use of integrated behavioural z-scoring in behavioural neuroscience – A perspective article
Ann-Katrin Kraeuter
Journal of Neuroscience Methods (2022) Vol. 384, pp. 109751-109751
Open Access | Times Cited: 11
Circadian light therapy and light dose for depressed young people: a systematic review and meta-analysis
Ranpeng Chen, Yonghong Yan, Cheng Xiang
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 2
Diagnostic value of MicroRNAs for depression: A systematic review and meta-analysis
Wenhui Li, Xingxing Li, Yannan Li, et al.
Journal of Psychiatric Research (2022) Vol. 157, pp. 132-140
Closed Access | Times Cited: 10
MiR-182-5p: A Novel Biomarker in the Treatment of Depression in CSDS-Induced Mice
Yabin Zheng, Xiaoming Sheng, Xiang Jin, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 5
Mahonia Alkaloids (MA) Ameliorate Depression Induced Gap Junction Dysfunction by miR-205/Cx43 Axis
Junhui He, Dongmei Li, Jie Wei, et al.
Neurochemical Research (2022) Vol. 47, Iss. 12, pp. 3761-3776
Closed Access | Times Cited: 9
MAPK Is a Mutual Pathway Targeted by Anxiety-Related miRNAs, and E2F5 Is a Putative Target for Anxiolytic miRNAs
Javad Amini, Cordian Beyer, Adib Zendedel, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 544-544
Open Access | Times Cited: 4
Marasmius androsaceus mitigates depression-exacerbated intestinal radiation injuries through reprogramming hippocampal miRNA expression
Jiamin Zhao, Xiaozhou Zeng, Jia Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115157-115157
Open Access | Times Cited: 4
The role of epigenetics in anxiety disorders
Ali Azargoonjahromi
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9625-9636
Closed Access | Times Cited: 4
Active Fraction of Polyrhachis Vicina Roger (AFPR) Ameliorate Depression Induced Inflammation Response by FTO/miR-221-3p/SOCS1 Axis
Junhui He, Jiaxiu Xie, Guili Zhou, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 6329-6348
Open Access | Times Cited: 4
Expression and role of microRNA-212/nuclear factor I-A in depressive mice
Liang Si, Yanyan Wang, Min Liu, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 11520-11532
Open Access | Times Cited: 10
Neuronally-enriched exosomal microRNA-27b mediates acute effects of ibuprofen on reward-related brain activity in healthy adults: a randomized, placebo-controlled, double-blind trial
Kaiping Burrows, Leandra K. Figueroa‐Hall, Rayus Kuplicki, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Late-onset major depressive disorder: exploring the therapeutic potential of enhancing cerebral brain-derived neurotrophic factor expression through targeted microRNA delivery
Giovanni Lai, Marco Malavolta, Serena Marcozzi, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Scroll to top